Medical/Pharmaceuticals

Earable(R) Disrupts Sleep Tech with FRENZ(TM) Brainband Global Launch Event at CES 2023

LAS VEGAS, Jan. 7, 2023 /PRNewswire/ -- Earable® Neuroscience held a global launch event for its FRENZ™ Brainband at CES 2023. During the event, the company discussed innovations behind the award-winning device, potential to disrupt sleep tech, a special promotional price, and its 88 Pioneer proj...

2023-01-07 08:00 4295

Parnell Pharmaceuticals Holdings Ltd Announces Extension of Rights Offering

SYDNEY, Jan. 6, 2023 /PRNewswire/ -- Parnell Pharmaceuticals Holdings Ltd (OTC Pink® Open Market: PARNF) ("Parnell") today announced the extension of the backstopped rights offering to raise gross proceeds of approximatelyUS$4.0 million (the "Rights Offering"). Under the terms of the Rights Offer...

2023-01-06 15:05 3981

CES 2023: OMRON Healthcare to Unveil New Efforts to Realize Vision of "Going for Zero" -- Zero Heart Attacks and Zero Strokes

- "Viso," New UK Remote Patient Monitoring Service, to Be Launching in Early 2023 - KYOTO, Japan, Jan. 6, 2023 /PRNewswire/ -- OMRON Healthcare Co., Ltd. (hereinafter the Company) is unveiling a new UK remote patient-monitoring service to realize its "Going for Zero" vision to eliminate heart at...

2023-01-06 14:00 2904

Innovent Announces the National Medical Products Administration in China Has Accepted and Granted Priority Review Designation to the New Drug Application for Parsaclisib (PI3Kδ inhibitor) for the Treatment of Relapsed or Refractory Follicular Lymphoma

ROCKVILLE, Md. and SUZHOU, China, Jan. 6, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and...

2023-01-06 12:22 4014

Kira to Present at the 41st Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass. and SUZHOU, China, Jan. 5, 2023 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced that Frederick Beddingfield M.D., Ph.D., Chief Executive Officer, will present a...

2023-01-05 23:30 2664

AMR Action Fund Announces Investment in BioVersys AG

Deal marks Fund's first investment in Europe and advances its mission of enabling the launch of two to four antimicrobials by 2030 BOSTON, Jan. 5, 2023 /PRNewswire/ --  The AMR Action Fund, the world's largest public-private partnership investing in biotech companies that are developing antimicr...

2023-01-05 20:00 7738

Dr. Steve Mark Gan and Gan Advanced Osseointegration Center (GAOC) Group of Companies Honored at the Asia Pacific Enterprise Awards 2022 Regional Edition

SINGAPORE, Jan. 5, 2023 /PRNewswire/ -- Enterprise Asia, the organizer of the Asia Pacific Enterprise Awards (APEA) 2022 Regional Edition, is pleased to recognize 25 exemplary business leaders and enterprises acrossAsia which excelled and showcased unparalleled resilience and growth despite the C...

2023-01-05 17:28 2442

Novogene Announces Deployment of Illumina NovaSeq™ X Plus and PacBio REVIO Sequencing Systems

SINGAPORE, Jan. 5, 2023 /PRNewswire/ -- Novogene , a leading provider of genomic services and solutions, announced the addition of Illumina's latest high-throughput sequencing systemNovaSeq™ X Plus and PacBio's Revio™ long-read sequencing sys...

2023-01-05 17:00 2785

Aurisco cooperates with Cytiva to build its first Oligo FlexFactory for commercial production

* Located in Yangzhou of East China, Aurisco's new commercial manufacturing site is expected to produce 200 kilograms of oligonucleotides each year. * Through the cooperation with Cytiva, Aurisco will deliver more oligonucleotides to its global customers with better quality and efficiency. SH...

2023-01-05 14:36 1826

DiscGenics to Present at 41st Annual J.P. Morgan Healthcare Conference

SALT LAKE CITY, Jan. 5, 2023 /PRNewswire/ -- DiscGenics, Inc., a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that it w...

2023-01-05 08:00 2038

Innovent Announces NMPA's Breakthrough Therapy Designation for IBI351 (KRAS G12C Inhibitor) as Monotherapy for Previous Treated Advanced Non-small Cell Lung Cancer

ROCKVILLE, Md. and SUZHOU, China, Jan. 5, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...

2023-01-05 08:00 3895

Cognos Therapeutics, Inc. to Become Publicly Listed on Nasdaq via Business Combination with Nocturne Acquisition Corporation

* Cognos Therapeutics is a medical technology company focused on developing unique, radically advanced devices for the treatment of neurological diseases including brain and spinal cancers, and degenerative neurological conditions (such as Alzheimer's and Parkinson's disease), epilepsy, and str...

2023-01-05 07:10 4166

Innovent to Present at 41st Annual J.P. Morgan Healthcare Conference

ROCKVILLE, Md. and SUZHOU, China, Jan. 5, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, o...

2023-01-05 00:00 2556

Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program

* Synaffix to provide Hummingbird Bioscience access to proprietary ADC technologies * Synaffix to receive up to $150m in upfront and milestone payments plus royalties  SAN FRANCISCO, HOUSTON and SINGAPORE, Jan. 4, 2023 /PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused ...

2023-01-04 21:00 2487

Alphyn Biologics Reports Positive Results from First Cohort of Phase 2a Trial of Mild-to-Moderate Atopic Dermatitis Treatment

Study met all primary endpoints ANNAPOLIS, Md., Jan. 4, 2023 /PRNewswire/ -- Alphyn Biologics, a clinical-stage dermatology company developing first-in-class multi-target therapeutics, announced today positive results from the first cohort of its Phase 2a clinical trial of AB-101a, a topical the...

2023-01-04 20:30 2196

China's optimization of control measures lays solid foundation for COVID-19 response

BEIJING, Jan. 4, 2023 /PRNewswire/ -- A report from People's Daily: Local authorities and relevant departments inChina have been making unremitting efforts recently to ensure the supply of medical resources, satisfy the demand for medicines and focus on the prevention and treatment of high-risk g...

2023-01-04 15:39 2424

Pulnovo Medical Announces Dr. Mingdong Zhang, Former FDA Medical Device Officer Joins Scientific Advisory Board

SHANGHAI, Jan. 4, 2023 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platform, announced the appointment of Dr.Mingdong Zhang to the company's Scientific Advisory Board (SAB). Dr. Zhang will provide guidance on Pulnovo Medical's clinical development and registration strategya...

2023-01-04 10:46 2295

Bioniq® Repair Toothpaste with 20% BioHAP*, scientifically proven to remineralise enamel and keeps teeth healthy and strong

HONG KONG, Jan. 4, 2023 /PRNewswire/ -- While most Westerners prefer trimmed meat and fish fillets, a vast majority of Asian diners enjoy eating their food off bones, picking flesh from carcasses, and gnawing on tendons,cartilage, and bones for gooey, chewy textures1. Hong Kong, a food paradise ...

2023-01-04 10:00 3846

Transcenta Received IND Clearance from NMPA for Its First-In-Class Gremlin1 Targeting Antibody TST003 for the Treatment of Solid Tumors

SUZHOU, China, Jan. 4, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics,announces that TST003, its first...

2023-01-04 08:00 2615

Sisram Medical to Present Virtually at the 25th Annual Needham Growth Conference

CAESAREA, Israel, Jan. 3, 2023 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group featuring a first-of-its-kind synergistic ecosystem of business building blo...

2023-01-03 21:30 1371
1 ... 139140141142143144145 ... 398